跳至主要内容
临床试验/NCT00847275
NCT00847275Unknown不适用

Behaviour and Cognitive Evaluation for Dialysis Elderly Patients

Nantes University Hospital1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2008年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
500
试验地点
1
主要终点
First outcome reached among: - death, - occurrence of a severe dementia (MMS < 10),- major depression detected by GDS-15 > 10/15 and confirmed by DSM-IV criteria,- severe dependency (ADL < 3/6).

研究概览

简要总结

The trial is a multicenter, prospective, randomized, open study. A total of 500 elderly patients aged over 75 years with renal insufficiency stage 5 will be included in the study after signed informed consent. Patients will be randomized 1/1 in two arms : 250 patients in the "exclusive nephrology follow-up" arm will continue their usual follow-up; 250 patients in the "geriatric follow-up" arm will have both their usual nephrology follow-up and a geriatric follow-up.The aim of the study is to determine if a systematized gerontologist evaluation delay the occurrence of a composite primary endpoint : death, dementia, depression and severe dependency. The hypothesis is that the functional and vital prognosis of a patient with renal insufficiency depends not only on common and classical factors but also on cognitive and psychological functions and dependence, particularly in elderly patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
75 Years 至 —(Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients aged of 75 years old or more,
  • •Chronic kidney disease stage 5 defined by :
  • •either an estimated GFR (MDRD) ≤ 15ml/mn/1,73 m² in a non-dialysis patient whatever the duration of previous monitoring by the nephrologist("Pre-dialysis cohort"),
  • •or a dialysis treatment started for more than 3 months and less than one year, whatever the duration of pre-dialysis follow-up by the nephrologist("post-dialysis cohort"),
  • •Signed and dated informed consent.

排除标准

  • •Moderately severe to severe dementia (MMS ≤ 15),
  • •Major depression and/or GDS-15 > 10/15,
  • •Severe dependency (ADL < 3/6),
  • •Psychosis, mutism or aphasia,
  • •Malignancy or any pathology with life expectancy < one year,
  • •Ongoing specialized geriatric care

研究组 & 干预措施

1

Placebo Comparator

"Exclusive nephrology follow-up" arm

干预措施: Exclusive nephrology follow-up (Other)

2

Experimental

"Geriatric follow-up" arm

干预措施: Geriatric follow-up (Other)

结局指标

主要结局

First outcome reached among: - death, - occurrence of a severe dementia (MMS < 10),- major depression detected by GDS-15 > 10/15 and confirmed by DSM-IV criteria,- severe dependency (ADL < 3/6).

时间窗: 3 years

次要结局

  • Secondary outcomes are: - cognitive, psychic and autonomy scores,- cardiovascular morbidity and mortality,- biological follow-up of chronic kidney disease including haemoglobin level.(3 years)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验